BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 9836530)

  • 1. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group.
    Antonetti DA; Barber AJ; Khin S; Lieth E; Tarbell JM; Gardner TW
    Diabetes; 1998 Dec; 47(12):1953-9. PubMed ID: 9836530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF164 is proinflammatory in the diabetic retina.
    Ishida S; Usui T; Yamashiro K; Kaji Y; Ahmed E; Carrasquillo KG; Amano S; Hida T; Oguchi Y; Adamis AP
    Invest Ophthalmol Vis Sci; 2003 May; 44(5):2155-62. PubMed ID: 12714656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
    Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
    Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability.
    Harhaj NS; Felinski EA; Wolpert EB; Sundstrom JM; Gardner TW; Antonetti DA
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):5106-15. PubMed ID: 17065532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group.
    Barber AJ; Antonetti DA; Gardner TW
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3561-8. PubMed ID: 11006253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping the blood vessels with paracellular permeability in the retinas of diabetic rats.
    Barber AJ; Antonetti DA
    Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5410-6. PubMed ID: 14638745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylglyoxal induces hyperpermeability of the blood-retinal barrier via the loss of tight junction proteins and the activation of matrix metalloproteinases.
    Kim J; Kim CS; Lee YM; Jo K; Shin SD; Kim JS
    Graefes Arch Clin Exp Ophthalmol; 2012 May; 250(5):691-7. PubMed ID: 22249316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norrin restores blood-retinal barrier properties after vascular endothelial growth factor-induced permeability.
    Díaz-Coránguez M; Lin CM; Liebner S; Antonetti DA
    J Biol Chem; 2020 Apr; 295(14):4647-4660. PubMed ID: 32086377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endostatin modulates VEGF-mediated barrier dysfunction in the retinal microvascular endothelium.
    Brankin B; Campbell M; Canning P; Gardiner TA; Stitt AW
    Exp Eye Res; 2005 Jul; 81(1):22-31. PubMed ID: 15978251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of experimental diabetic vascular leakage by delivery of angiostatin with a recombinant adeno-associated virus vector.
    Shyong MP; Lee FL; Kuo PC; Wu AC; Cheng HC; Chen SL; Tung TH; Tsao YP
    Mol Vis; 2007 Jan; 13():133-41. PubMed ID: 17293777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas.
    Murata T; Nakagawa K; Khalil A; Ishibashi T; Inomata H; Sueishi K
    Lab Invest; 1996 Apr; 74(4):819-25. PubMed ID: 8606491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel co-culture model of the blood-retinal barrier based on primary retinal endothelial cells, pericytes and astrocytes.
    Wisniewska-Kruk J; Hoeben KA; Vogels IM; Gaillard PJ; Van Noorden CJ; Schlingemann RO; Klaassen I
    Exp Eye Res; 2012 Mar; 96(1):181-90. PubMed ID: 22200486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free insulin-like growth factor binding protein-3 (IGFBP-3) reduces retinal vascular permeability in association with a reduction of acid sphingomyelinase (ASMase).
    Kielczewski JL; Li Calzi S; Shaw LC; Cai J; Qi X; Ruan Q; Wu L; Liu L; Hu P; Chan-Ling T; Mames RN; Firth S; Baxter RC; Turowski P; Busik JV; Boulton ME; Grant MB
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8278-86. PubMed ID: 21931131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlorogenic acid decreases retinal vascular hyperpermeability in diabetic rat model.
    Shin JY; Sohn J; Park KH
    J Korean Med Sci; 2013 Apr; 28(4):608-13. PubMed ID: 23579598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of clusterin on blood-retinal barrier breakdown in diabetic retinopathy.
    Kim JH; Kim JH; Yu YS; Min BH; Kim KW
    Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1659-65. PubMed ID: 19875648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF-initiated blood-retinal barrier breakdown in early diabetes.
    Qaum T; Xu Q; Joussen AM; Clemens MW; Qin W; Miyamoto K; Hassessian H; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2408-13. PubMed ID: 11527957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of MAPKs in endostatin-mediated regulation of blood-retinal barrier function.
    Campbell M; Collery R; McEvoy A; Gardiner TA; Stitt AW; Brankin B
    Curr Eye Res; 2006 Dec; 31(12):1033-45. PubMed ID: 17169842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
    Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
    Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetes.
    Leal EC; Martins J; Voabil P; Liberal J; Chiavaroli C; Bauer J; Cunha-Vaz J; Ambrósio AF
    Diabetes; 2010 Oct; 59(10):2637-45. PubMed ID: 20627932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin protects outer blood-retinal barrier in experimental diabetic retinopathy by up-regulating ZO-1 and occludin.
    Zhang C; Xie H; Yang Q; Yang Y; Li W; Tian H; Lu L; Wang F; Xu JY; Gao F; Wang J; Jin C; Xu G; Xu GT; Zhang J
    Clin Exp Ophthalmol; 2019 Dec; 47(9):1182-1197. PubMed ID: 31483932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.